Evolutionary Tree Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Evolutionary Tree Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-92,898	Closed	-$1.87M	–	48
2021 Q3	$1.87M	Sell	92,898 -48,426	-34%	-$1.34M	0.83%	36
2021 Q2	$5.27M	Buy	141,324 +18,851	+15%	+$578K	2.43%	19
2021 Q1	$3.13M	Buy	122,473 +61,609	+101%	+$1.57M	1.85%	22
2020 Q4	$1.34M	Buy	+60,864	New	+$1.34M	1.02%	33

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Evolutionary Tree Capital Management's DRNA Position: Q4 2021 in Review

Evolutionary Tree Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 92,898 shares — an estimated $1.87M sold.

Evolutionary Tree Capital Management first reported a position in DRNA in Q4 2020 and held it in 4 quarters. The position peaked at $5.27M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Evolutionary Tree Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Evolutionary Tree Capital Management sold 92,898 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.87M.
Evolutionary Tree Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
Evolutionary Tree Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $5.27M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Evolutionary Tree Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.